Home/Filings/4/0000950170-25-018136
4//SEC Filing

Ghai Jyotsna 4

Accession 0000950170-25-018136

CIK 0001850906other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:57 PM ET

Size

7.0 KB

Accession

0000950170-25-018136

Insider Transaction Report

Form 4
Period: 2025-02-09
Ghai Jyotsna
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-092503,000 total
    Common Stock (250 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-09+2503,283 total
Footnotes (3)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The RSUs vest in 16 equal quarterly installments over four years measured from February 9, 2024.

Documents

1 file

Issuer

Singular Genomics Systems, Inc.

CIK 0001850906

Entity typeother

Related Parties

1
  • filerCIK 0001999779

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:57 PM ET
Size
7.0 KB